Patents by Inventor Huaxian Zheng

Huaxian Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tablet of sporoderm-removed ganoderma lucidum spore and preparation method thereof
    Patent number: 11931389
    Abstract: The present invention provides a tablet of sporoderm-removed Ganoderma lucidum spore, which includes the following raw materials by weight parts: 13-20 parts of an aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, 3-5 parts of sorbitol, and 0.8-1.2 parts of povidone K30; A method for preparing the tablet of sporoderm-removed Ganoderma lucidum spore includes the following steps: mixing the aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, sorbitol and povidone K30 for 10-30 min, and subjecting the obtained mixture to granulating, screening and drying to obtain a granular material; and tableting the granular material to obtain the tablet of sporoderm-removed Ganoderma lucidum spore. The tablet of sporoderm-removed Ganoderma lucidum spore has a much higher content of active components, which are also easier to be absorbed.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: March 19, 2024
    Assignees: Zhejiang Shouxiangu Pharmaceutical Company, Ltd., Jinhua Shouxiangu Pharmaceutical Co. Ltd
    Inventors: Zhenhao Li, Mingyan Li, Ying Wang, Huaxian Zheng, Jing Xu
  • TABLET OF SPORODERM-REMOVED GANODERMA LUCIDUM SPORE AND PREPARATION METHOD THEREOF
    Publication number: 20190343906
    Abstract: The present invention provides a tablet of sporoderm-removed Ganoderma lucidum spore, which includes the following raw materials by weight parts: 13-20 parts of an aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, 3-5 parts of sorbitol, and 0.8-1.2 parts of povidone K30; A method for preparing the tablet of sporoderm-removed Ganoderma lucidum spore includes the following steps: mixing the aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, sorbitol and povidone K30 for 10-30 min, and subjecting the obtained mixture to granulating, screening and drying to obtain a granular material; and tableting the granular material to obtain the tablet of sporoderm-removed Ganoderma lucidum spore. The tablet of sporoderm-removed Ganoderma lucidum spore has a much higher content of active components, which are also easier to be absorbed.
    Type: Application
    Filed: June 2, 2018
    Publication date: November 14, 2019
    Inventors: Zhenhao Li, Mingyan Li, Ying Wang, Huaxian Zheng, Jing Xu